Evidence map›Paper›PMID 30296925›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2019

Block of Granulocyte-Macrophage Colony-Stimulating Factor Prevents Inflammation-Induced Preterm Birth in a Mouse Model for Parturition.

Christopher Nold, Julie Stone, Kathleen O'Hara, Patricia Davis, Vladislav Kiveliyk, Vanessa Blanchard, Steven M Yellon, Anthony T Vella

Open access · bronzeAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Protective effects of engineeredFrontiers in veterinary science · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Trophoblasts Modulate the CaOxidative medicine and cellular longevity · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Christopher Nold1 Department of Women's Health, Hartford Hospital, Hartford, CT, USA.
Julie Stone2 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
Kathleen O'Hara2 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
Patricia Davis2 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
Vladislav Kiveliyk2 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
Vanessa Blanchard3 Longo Center for Perinatal Biology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Steven M Yellon3 Longo Center for Perinatal Biology, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Anthony T Vella2 Department of Pediatrics, University of Connecticut School of Medicine, Farmington, CT, USA.
University of Connecticut · USLoma Linda University · USHartford Hospital · US

Funding

NEURAL REGULATION OF PREPARTUM CERVICAL RIPENINGR01HD054931 · NICHD · LOMA LINDA UNIVERSITY · PI YELLON, STEVEN M · 2007 to 2016
$2.2M
NICHD NIH HHS R01 HD054931
6 · The paper itself

Abstract

objectiveA multitude of factors promotes inflammation in the reproductive tract leading to preterm birth. Macrophages peak in the cervix prior to birth and their numbers are increased by the cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF). We hypothesize GM-CSF is produced from multiple sites in the genital tract and is a key mediator in preterm birth. STUDY

designEctocervical, endocervical, and amniotic fluid mesenchymal stem cells were treated with lipopolysaccharide (LPS), and the concentration and expression of GM-CSF was measured. Pregnant CD-1 mice on gestational day 17 received LPS and an intravenous injection of either anti-mouse GM-CSF or control antibody. After 6 hours, the preterm birth rate was recorded.

resultsTreatment with LPS increased the GM-CSF concentration and messenger RNA expression after 24 hours in all 3 cell lines ( P < .01). Mice treated with LPS and the GM-CSF antibody had a preterm birth rate of 25%, compared to a 66.7% preterm birth rate in controls, within 6 hours ( P < .05, χ

conclusionThese studies demonstrate that GM-CSF is produced from multiple sites in the genital tract and that treatment with an antibody to GM-CSF prevents preterm birth. Curiously, the anti-mouse GM-CSF antibody did not decrease the number of macrophages in the cervix. Further research is needed to determine whether antibodies to GM-CSF can be utilized as a therapeutic agent to prevent preterm birth.

Indexed as

AnimalsCell LineCervix UteriDisease Models, AnimalFemaleGranulocyte-Macrophage Colony-Stimulating FactorHumansInflammationLipopolysaccharidesMesenchymal Stem CellsMiceParturitionPremature BirthRNA, MessengerGranulocyte-Macrophage Colony-Stimulating FactorLipopolysaccharidesRNA, Messengercervical remodelinginflammationpreterm birth

Identifiers

PMID30296925
PMCPMC6421621
OpenAlexW2896143105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.